Novel effects of macrostemonoside A, a compound from Allium macrostemon Bung, on hyperglycemia, hyperlipidemia, and visceral obesity in high-fat diet-fed C57BL/6 mice

European Journal of Pharmacology

Volumn 599, Issue 1-3, 2008, Pages 159-165

  Xie, Weidong ^a   Zhang, Yaou ^a   Wang, Naili ^a   Zhou, Hua ^a   Du, Lijun ^b   Ma, Xiaohui ^a   Shi, Xiaojun ^a   Cai, Guoping ^a  

^a Graduate School at Shenzhen   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Macrostemonoside A; Metabolic syndrome; Obesity; Peroxisome proliferators activated receptor gamma 2; Sibutramine; Type 2 diabetes; Visfatin

Indexed keywords

MACROSTEMONOSIDE A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLANT EXTRACT; SIBUTRAMINE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VISFATIN;

ALLIUM MACROSTEMON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GARLIC; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEART PROTECTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALLIUM; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY FATS; DISEASE MODELS, ANIMAL; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INTRA-ABDOMINAL FAT; LIPASE; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; OBESITY; PPAR GAMMA; SAPONINS; STEROIDS; UP-REGULATION;

EID: 54949112021     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.09.042     Document Type: Article

References (41)

1. Allain C.C., Poon L.C., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total cholesterol. Clin. Chem. 20 (1974) 470-475
2. Aouadi, M., Jager, J., Laurent, K., Gonzalez, T., Cormont, M., Binétruy, B., Le Marchand-Brustel, Y., Tanti, J.F., Bost, F., 2007. p.38. MAP Kinase activity is required for human primary adipocyte differentiation. FEBS Lett. 581, 5591-5596.
3. Boozer C.N., Leibel R.L., Love R.J., Cha M.C., and Aronne L.J. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Metabolism 50 (2001) 889-893
4. Bray G.A., and Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29 (2006) 109-117
5. Buettner R., Schölmerich J., and Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15 (2007) 798-808
6. Coletta D.K., Bates S.H., Jones R.B., and Bailey C.J. The sibutramine metabolite M2 improves muscle glucose uptake and reduces hepatic glucose output: preliminary data. Diab. Vasc. Dis. Res. 3 (2006) 186-188
7. Day C., and Bailey C.J. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 619-623
8. Esposito K., Ceriello A., and Giugliano D. Diet and the metabolic syndrome. Metab. Syndr. Relat. Disord. 5 (2007) 291-296
9. Farmer S.R. Regulation of PPAR gamma activity during adipogenesis. Int. J. Obes. (Lond.) 29 Suppl. 1 (2005) S13-S16
10. Fossati P., and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produce hydrogen peroxide. Clin. Chem. 28 (1982) 2077-2080
11. Filippatos T.D., Kiortsis D.N., Liberopoulos E.N., Mikhailidis D.P., and Elisaf M.S. A review of the metabolic effects of sibutramine. Curr. Med. Res. Opin. 21 (2005) 457-468
12. Fujioka K. Metabolic syndrome treatment strategies. Pharmacotherapy 26 (2006) S222-S226
13. Ji Y.Z. Recent research review and development prospect of Allium macrostemon Bung (Xie Bai). Tianjin Pharm. 17 (2005) 54-56 (Article in Chinese)
14. Jocken J.W., Langin D., Smit E., Saris W.H., Valle C., Hul G.B., Holm C., Arner P., and Blaak E.E. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J. Clin. Endocrinol. Metab. 92 (2007) 2292-2299
15. Kerscher L., Schiefer S., Draeger B., Maier J., and Ziegenhorn J. Precipitation methods for the determination of LDL-cholesterol. Clin. Biochem. 18 (1985) 118-125
16. Krejs G.J. Metabolic benefits associated with sibutramine therapy. Int. J. Obes. Relat. Metab. Disord. 26 Suppl 4 (2002) S34-S37
17. Liberopoulos E.N., Mikhailidis D.P., and Elisaf M.S. Diagnosis and management of the metabolic syndrome in obesity. Obes. Rev. 6 (2005) 283-296
18. Liu G.Q. A research of Malate dehydrogenase activity in various tissues on rabbits and mice. Acta Scientiarum Naturatlium Univerisitatis Nankaiensis 38 (2005) 44-47 (Article in Chinese)
19. Izzo C., Grillo F., and Murador E. Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem. 27 (1981) 371-374
20. Matfin G. Challenges in developing drugs for the metabolic syndrome. Curr. Diab. Rep. 8 (2008) 31-36
21. Nedergaard J., Petrovic N., Lindgren E.M., Jacobsson A., and Cannon B. PPAR gamma in the control of brown adipocyte differentiation. Biochim. Biophys. Acta. 1740 (2005) 293-304
22. Nemeth P.M., Rosser B.W., Choksi R.M., Norris B.J., and Baker K.M. Metabolic response to a high-fat diet in neonatal and adult rat muscle. Am. J. Physiol. 262 (1992) C282-286
23. Normile D. Comment on: Science. 2005 Jan 21; 307(5708): 426-30. Scientific publishing. Osaka University researchers reject demand to retract Science paper. Science 316 (2007) 1681
24. Peng J.P., Wu Y., Yao X.S., Okuyama T., and Narui T. Two new steroidal saponins from Allium macrostemon. Yao Xue Xue Bao 27 (1992) 918-922 (Article in Chinese)
25. Richardson D.K., Jones R.B., and Bailey C.J. The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice, and in isolated human adipocytes. Horm. Metab. Res. 38 (2006) 727-731
26. Rutter M.K., Meigs J.B., and Wilson P.W. Cardiovascular risk and the metabolic syndrome. Metab. Syndr. Relat. Disord. 4 (2006) 252-260
27. Sampson M., Ruddel M., and Elin R.J. Effects of specimen turbidity and glycerol concentration on nine enzymatic methods for triglyceride determination. Clin. Chem. 40 (1994) 221-226
28. Sethi J.K. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?. Curr. Hypertens. Rep. 9 (2007) 33-38
29. Shaw D.I., Hall W.L., and Williams C.M. Metabolic syndrome: what is it and what are the implications?. Proc. Nutr. Soc. 64 (2005) 349-357
30. Spinler S.A. Challenges associated with metabolic syndrome. Pharmacotherapy 26 (2006) 209S-217S
31. Sun W.J., Liu J., Yang S.J., Zhou Q.W., and Zhao M. Influences of extracts of long-stalk Xie Bai (Allium macrostemon Bung) with different areas in lipid metabolism and anti-oxidative activities in hyperlipidemic rats. J. Norman Bethune Univ. Med. Sci. 5 (1999) 259-260 (Article in Chinese)
32. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6 (1969) 24-27
33. Vidal-Puig A., Jimenez-Liñan M., Lowell B.B., Hamann A., Hu E., Spiegelman B., Flier J.S., and Moller D.E. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97 (1996) 2553-2561
34. Wang Y., Zhu X.U., and Zhou G.H. Method for determination of hepatin in chilled meat. Meat Res. 2 (2007) 29-32
35. Xie W.D., Xing D.M., Sun H., Wang W., Ding Y., and Du L.J. Novel activities of anti-diabetes, anti-dyslipidemia and anti-oxidation in vivo for ethanol extracts of leaves of Ananas comosus L. in diabetic-dyslipidemic rats induced by alloxan and a high-fat, high-cholesterol diet. Am. J. Chin. Med. 33 (2005) 95-105
36. Yeo J., Lee Y.H., Jeon S.M., Jung U.J., Lee M.K., Jung Y.M., and Choi M.S. Supplementation of a novel microbial biopolymer, PGB1, from new Enterobacter sp. BL-2 delays the deterioration of type 2 diabetic mice. J. Microbiol. Biotechnol. 17 (2007) 1983-1990
37. Zhang Q., and Gao E. Advances in the study of Allium Macrostemon Bunge. China J. Chin. Mater. Med. 28 (2003) 105-107 (Article in Chinese)
38. Zhang K.C., and Ji H.H. Advance on the research of extraction and activity assay of succinate dehydrogenas. Zhong Guo Zhong Yi Yao Za Zhi 5 (2007) 32-33 (Article in Chinese)
39. Zhou H., Yang X., Wang N.L., Zhang Y.O., and Cai G.P. Macrostemonoside A promotes visfatin expression in 3T3-L1 cells. Biol. Pharm. Bull. 30 (2007) 279-283
40. Zhou H., Yang X., Wang N., Zhang Y., and Cai G. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol. Cell. Endocrinol. 270 (2007) 17-22
41. Zhu B., Wan C.M., Guo H.L., Xiao J., and Wang Z.R. A study on changes of myosin ATPase activities in cardiac ischemic reperfusion injury of rabbits. J. Sichuan Univ. (Med. Sci. Edi.) 35 (2007) 179-181 (Article in Chinese)